Crispr Therapeutics Ag (CRSP)

Capital Expenditure

-$4.22M

TTM · Period ending: · USD

CRSP logo

CRSP Capital Expenditure

Latest reported-$4.22M
CRSP TTM CapEx (-$1.15M → -$4.22M)
High-resolution chart · PNG

CRSP capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Crispr Therapeutics Ag Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-4,216,000
-1,212,000
-914,000
-651,000
-796,000
-1,386,000
-1,901,000
-2,385,000
-4,284,000
-7,132,000
-9,470,000
-14,923,000
-18,822,000
-24,897,000
-37,188,000
-40,180,000
-71,212,000
-90,031,000
-81,705,000
-78,761,000
-47,235,000
-22,391,000
-18,358,000
-13,071,000
-10,009,000
-8,578,000
-6,684,000
-6,732,000
-4,966,000
-3,315,000
-2,773,000
-1,978,000
-4,277,000
-5,084,000
-7,814,000
-7,837,000
-6,352,000
-6,069,000
-3,016,000
-3,291,000
-2,331,000
-1,386,000
-1,154,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.